:: Volume 21, Issue 1 (1-2023) ::
Int J Radiat Res 2023, 21(1): 163-167 Back to browse issues page
Effective management of a patient with secondary male breast cancer after neck radiotherapy for tonsillar lymphoma
F. Tramacere, A.R. Pisani, E. Maggiulli, M. Moschetta, A. Sardaro, C. Altini, A. Sciacqua, M. Portaluri
Section of radiotherapy, DIM, University “Aldo Moro”, 70124 Bari, Italy , angelasardaro@libero.it
Abstract:   (135 Views)
Recent advances in surgical techniques, chemotherapy and radiotherapy led to significant increase in the number of long-term cancer survivors, but on other hand with increased probability of adverse effects, including the development of a secondary malignant neoplasm. This is especially important to consider when there is the need to provide treatment recommendations for patients undergoing radiotherapy keeping in mind the potential risks of toxicity associated with possession of specific genetic variants. We reported the clinical case of a patient in whom rare malignancies associated to genetic mutation have been treated and managed in the best way thanks to the support of radiotherapist. In particular a male patient with positive family history of BRCA2 mutation, developed breast cancer after radiotherapy for a rare tonsillar non-Hodgkin Lymphoma. We highlight that the knowledge of all aspects of the diseases, of all treatments secondary effects, in particular of ionizing radiation in patients with potential genetic risk of toxicity, allowed an optimal management of the case.
Keywords: Male breast cancer, BRCA2 mutation, secondary malignant neoplasm, non-Hodgkin lymphoma, radiation therapy.
Full-Text [PDF 579 kb]   (131 Downloads)    
Type of Study: Case Report | Subject: Radiation Biology

XML     Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 1 (1-2023) Back to browse issues page